利用统计模型研究骨量流失与阿尔茨海默病之间的因果关系。
The cause-effect relationship between bone loss and Alzheimer's disease using statistical modeling.
机构信息
American Academy of Family Physicians National Research Network, USA.
University of Kansas, Lawrence, KS, USA.
出版信息
Med Hypotheses. 2019 Jan;122:92-97. doi: 10.1016/j.mehy.2018.10.024. Epub 2018 Oct 29.
BACKGROUND
Animal studies provide strong evidence that the CNS directly regulates bone remodeling through the actions of the hypothalamus via two distinct pathways, the neural (mediated by leptin) arm and neurohumoral (mediated by neurohormones and growth factors) arm. The impact of AD on central regulatory mechanisms of bone mass is not known.
OBJECTIVES
To test a model that assesses the relationship between hypothalamic atrophy and bone loss in Alzheimer's disease (AD) and potential mediation through neural (leptin) and neurohumoral (insulin-like growth factor -1, IGF-1) mechanisms.
HYPOTHESES
AD-related hypothalamic structural change alters neural and neurohumoral regulatory systems of bone remodeling and contributes to bone loss in early AD.
DESIGN
A secondary data analysis of data obtained in a two-year longitudinal study with path analysis and longitudinal mediation modeling.
PARTICIPANTS
The data were collected as a part of the University of Kansas Brain Aging Project, a two-year observational study of 71 older adults with early stage AD and 69 non-demented controls.
MEASUREMENTS
Demographic characteristics and measures of bone density, body composition, and hypothalamic volume, serum levels of leptin, growth hormone, and IGF-1 were collected.
RESULTS
Hypothalamic atrophy and bone loss were observed in AD group and were associated. Data modeling suggests that bone loss may precede measurable changes in the brain. Leptin increased over two years in AD and the increase in leptin was associated with hypothalamic atrophy. However, changes in leptin or IGF-1 levels did not mediate the relationship between hypothalamic atrophy and bone loss.
CONCLUSIONS
This study extends previous findings by suggesting that bone loss in AD may be related to neurodegenerative changes (atrophy) in the hypothalamus. Further studies are needed to explore the role of brain atrophy and mediating mechanisms in bone loss. Further exploring temporal relationship between bone loss and AD may have an important diagnostic value.
背景
动物研究提供了强有力的证据,表明中枢神经系统通过下丘脑的两条不同途径直接调节骨重塑,即神经途径(由瘦素介导)和神经激素途径(由神经激素和生长因子介导)。AD 对骨量中枢调节机制的影响尚不清楚。
目的
测试一个评估阿尔茨海默病(AD)中下丘脑萎缩与骨丢失之间关系的模型,并通过神经(瘦素)和神经激素(胰岛素样生长因子-1,IGF-1)机制进行潜在的中介。
假设
AD 相关的下丘脑结构变化改变了骨重塑的神经和神经激素调节系统,并导致 AD 早期的骨丢失。
设计
对一项为期两年的纵向研究中获得的数据进行二次数据分析,采用路径分析和纵向中介模型。
参与者
数据是作为堪萨斯大学大脑老化项目的一部分收集的,该项目是一项为期两年的观察性研究,涉及 71 名早期 AD 患者和 69 名非痴呆对照者。
测量
收集人口统计学特征以及骨密度、身体成分和下丘脑体积、血清瘦素、生长激素和 IGF-1 水平的测量值。
结果
AD 组观察到下丘脑萎缩和骨丢失,两者相关。数据建模表明,骨丢失可能先于大脑可测量的变化。AD 患者的瘦素在两年内增加,瘦素的增加与下丘脑萎缩有关。然而,瘦素或 IGF-1 水平的变化并没有介导下丘脑萎缩与骨丢失之间的关系。
结论
本研究通过表明 AD 中的骨丢失可能与下丘脑的神经退行性变化(萎缩)有关,扩展了先前的发现。需要进一步研究来探索脑萎缩和中介机制在骨丢失中的作用。进一步探索骨丢失和 AD 之间的时间关系可能具有重要的诊断价值。